ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 5 filers reported holding ALBIREO PHARMA INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $57,677 | +22.7% | 2,669 | +9.0% | 0.00% | – |
| Q3 2022 | $47,000 | -7.8% | 2,449 | -5.2% | 0.00% | – |
| Q2 2022 | $51,000 | -8.9% | 2,583 | +38.4% | 0.00% | – |
| Q1 2022 | $56,000 | +27.3% | 1,867 | -2.3% | 0.00% | – |
| Q4 2021 | $44,000 | -25.4% | 1,911 | 0.0% | 0.00% | – |
| Q3 2021 | $59,000 | -15.7% | 1,911 | -3.3% | 0.00% | – |
| Q2 2021 | $70,000 | -1.4% | 1,976 | -1.9% | 0.00% | – |
| Q1 2021 | $71,000 | -11.2% | 2,014 | -5.5% | 0.00% | – |
| Q4 2020 | $80,000 | +27.0% | 2,132 | +11.9% | 0.00% | – |
| Q3 2020 | $63,000 | +2000.0% | 1,905 | +1786.1% | 0.00% | – |
| Q2 2020 | $3,000 | – | 101 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 480,000 | $14,318,000 | 9.25% |
| Decheng Capital Management III (Cayman), LLC | 518,342 | $15,462,000 | 4.74% |
| TANG CAPITAL MANAGEMENT LLC | 467,702 | $13,952,000 | 2.79% |
| Birchview Capital, LP | 113,000 | $3,371,000 | 2.43% |
| Privium Fund Management B.V. | 351,805 | $10,494,000 | 2.32% |
| Sio Capital Management, LLC | 144,546 | $4,312,000 | 1.43% |
| Perceptive Advisors | 2,360,139 | $70,403,000 | 1.41% |
| Chicago Capital, LLC | 1,011,744 | $30,180,000 | 1.30% |
| Endurant Capital Management LP | 120,834 | $3,604,000 | 0.95% |
| Nicholas Investment Partners, LP | 439,235 | $13,102,000 | 0.93% |